Allergy and Immunology Billing: Why the Denials Cluster on Unit Counts
An allergy practice billing 95165 for antigen preparation can lose $40,000-$90,000 a year to unit-count denials alone (typical ranges, not quotes), and almost none of it shows up as a coding error. The claims are clean, the documentation supports the service, and the denial still lands -- because the payer counted doses differently than the practice did. Unit definition, not code selection, is the dominant denial driver in allergy and immunology billing.
This article provides general operational guidance on medical billing practices. It is not legal, compliance, or financial advice. Consult qualified healthcare billing counsel or a certified professional coder for your specific situation.
Medicare audit rules and Local Coverage Determinations (LCDs) vary by MAC jurisdiction and change frequently. Verify current requirements with your MAC before acting on any guidance in this article.
Credentialing and enrollment requirements vary by payer and change frequently. Verify current requirements directly with each payer.
The Short Answer
Build your allergy revenue cycle around one question per payer: how does this payer define a billable dose for 95165, and what is the maximum number of units it will allow per vial. Get that answer in writing for your top five payers before you adjust anything else. Everything downstream -- vial preparation workflow, charge capture, appeal templates -- follows from the unit definition.
Why Allergy Billing Behaves Differently From General Practice Billing
Most specialty billing problems are documentation problems. Allergy billing is different because the core revenue codes are quantity-based rather than encounter-based. CPT 95165 covers professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, and it is billed per dose, not per visit. The practice mixes a multi-dose vial once and bills a number of units against it, so a single preparation event generates a unit count that a payer can dispute weeks later.
Medicare defines a billable dose under 95165 as a 1 mL aliquot from a multi-dose vial, and MAC jurisdictions commonly apply a maximum number of units per vial regardless of how many aliquots the practice actually draws. Commercial payers frequently do not follow that definition. Some adopt the Medicare aliquot rule, some pay per vial prepared, and some apply their own per-year maximum. The practice that bills every payer on one internal convention will be underpaid by some and recouped by others.
The injection codes carry a second, quieter problem. CPT 95115 covers a single allergen immunotherapy injection and 95117 covers two or more injections, and neither includes an office visit. When a nurse-administered injection visit gets an evaluation and management code appended without separately identifiable documentation, the E/M line is the one that draws the audit, not the injection.
| Code family | What it covers | Unit basis | Dominant denial driver | Who owns the fix |
|---|---|---|---|---|
| 95004 | Percutaneous skin tests, immediate reaction | Per test performed | Test count exceeds payer maximum per session | Clinical lead sets panel size |
| 95165 | Antigen preparation, multi-dose vial | Per dose, definition varies by payer | Unit count mismatch against payer dose definition | Billing vendor or in-house biller |
| 95115 / 95117 | Immunotherapy injection, single or multiple | Per injection encounter | E/M appended without separate documentation | Front office and provider |
| 95144 - 95149 | Single-dose vial antigen preparation | Per single-dose vial | Billed where a multi-dose code applies | Certified professional coder |
| 86003 / 86008 | Allergen-specific IgE testing | Per allergen | Medical necessity when billed alongside skin testing | Provider documentation |
The Payer Matrix Most Practices Never Build
The single highest-return artifact in an allergy revenue cycle is a one-page matrix listing each contracted payer, that payer's written dose definition for 95165, its maximum allowed units per vial, its maximum units per year, and whether it requires prior authorization for immunotherapy. Most practices operate without it and discover each payer's rule one denial at a time.
Build the matrix from primary sources: the payer's own medical policy or reimbursement policy document, not the billing staff's recollection and not the clearinghouse edit. Where a commercial payer publishes no policy, submit a written coverage inquiry and keep the response. A written payer response is what converts a denial appeal from an argument into a citation, and it is the same evidence that supports a refund position if the payer later reverses course.
Refresh the matrix at contract renewal. Unit maximums are a quiet contract term that moves without notice, and a payer that tightens a per-year maximum will not generally flag it -- the practice discovers it when claims that paid last quarter stop paying. This belongs in the same review cycle as your fee schedule and charge review.
How to Actually Fix the Denial Rate
- Pull a 12-month denial extract filtered to your allergy code families: sort by denial reason and dollars, not by claim count. Unit-count denials are individually small and collectively the largest bucket, so a count-sorted report hides them.
- Confirm the dose definition in writing for your top five payers: these typically carry 70-85% of immunotherapy volume, so five written answers resolve most of the exposure.
- Reconcile vial preparation records against billed units monthly: the preparation log is the source document. If billed units and prepared aliquots diverge, the gap is either lost revenue or recoupment exposure, and both need the same fix.
- Separate the injection visit from the E/M decision at the front desk: an injection-only visit should not route to an E/M charge by default. Make the default no E/M, and require the provider to affirmatively document a separately identifiable service.
- Template the unit-count appeal: most of these denials are appealable with the payer's own policy language and the preparation log. A reusable appeal packet turns a 45-minute research task into a 10-minute submission.
What Goes Wrong
- One internal unit convention applied to every payer: the practice bills its own dose definition uniformly, which guarantees underpayment at payers with a broader definition and recoupment at payers with a narrower one.
- Preparation logs kept clinically but not retained for billing: when the log is discarded or lives only in a paper binder, the practice cannot substantiate units on appeal and loses claims it would have won.
- Annual maximums tracked per calendar year when the payer uses a rolling 12 months: the mismatch produces a cluster of denials that looks random and is entirely predictable.
- Reflexive E/M on injection visits: this is the pattern most likely to escalate from denial into a documentation review, because it looks like a billing habit rather than a clinical judgment.
- Billing vendor evaluated on overall collection rate: a vendor performing well across a general book can be weak on allergy specifically. Ask for net collection rate on your allergy code families in isolation.
What Should You Do?
Treat unit definition as a contracting problem rather than a coding problem. Get the 95165 dose definition and the per-vial and per-year maximums in writing from your top five payers, build the one-page matrix, and reconcile preparation logs against billed units every month. Then measure your billing vendor on allergy-specific net collection rate rather than a blended number, because a blended number will hide exactly this failure. If the denial extract shows unit-count denials as the leading dollar bucket and the matrix does not exist, the matrix is the highest-return week of work available to the practice. Practice management and billing resources are available at GetPracticeHelp.
Get the full practice management guide at GetPracticeHelp -- with billing benchmarks, credentialing checklists, and revenue cycle best practices.
Frequently Asked Questions
- How does Medicare define a billable dose for CPT 95165?
- Medicare treats a dose as a 1 mL aliquot removed from a multi-dose vial, and MAC jurisdictions commonly apply a maximum number of billable units per vial. Because the maximum and its application vary by MAC, confirm the current rule with your own MAC rather than relying on a figure from another jurisdiction.
- Can an office visit be billed on the same day as an immunotherapy injection?
- Only when a separately identifiable evaluation and management service is documented and supports the level billed. CPT 95115 and 95117 do not include an E/M component, but appending an E/M by default to injection-only visits is a common audit trigger.
- Why do commercial payers deny 95165 units that Medicare pays?
- Commercial payers are not required to adopt Medicare's aliquot-based dose definition. Some pay per vial prepared, some set their own per-year maximums, and some follow Medicare. The definition is a payer-by-payer question, which is why the written matrix matters.
- What documentation supports a unit-count appeal?
- The antigen preparation log showing vial contents and aliquots prepared, paired with the payer's own published dose definition. Together these convert the appeal from a disagreement about practice into a citation of the payer's own policy.
- Should an allergy practice use a specialty billing vendor?
- It depends less on the specialty label than on measurable performance. Ask any candidate vendor for audited net collection rate and denial rate on allergy and immunology code families specifically, over at least 12 months. A vendor that can only produce blended book-wide numbers cannot demonstrate competence in the codes that drive this specialty.